These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8791240)

  • 1. Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine.
    Limmroth V; May A; Auerbach P; Wosnitza G; Eppe T; Diener HC
    J Neurol Sci; 1996 Jun; 138(1-2):60-5. PubMed ID: 8791240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks.
    Caekebeke JF; Ferrari MD; Zwetsloot CP; Jansen J; Saxena PR
    Neurology; 1992 Aug; 42(8):1522-6. PubMed ID: 1322512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraneurs.
    Diener HC; Peters C; Rudzio M; Noe A; Dichgans J; Haux R; Ehrmann R; Tfelt-Hansen P
    J Neurol; 1991 Aug; 238(5):245-50. PubMed ID: 1655985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan.
    Friberg L; Olesen J; Iversen HK; Sperling B
    Lancet; 1991 Jul; 338(8758):13-7. PubMed ID: 1676084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study.
    Lipton RB; Stewart WF; Cady R; Hall C; O'Quinn S; Kuhn T; Gutterman D
    Headache; 2000; 40(10):783-91. PubMed ID: 11135021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
    Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
    Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumatriptan and cerebral blood flow velocity changes during migraine attacks.
    Totaro R; De Matteis G; Marini C; Baldassarre M; Carolei A
    Headache; 1997; 37(10):635-9. PubMed ID: 9439084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache.
    Diener HC; Haab J; Peters C; Ried S; Dichgans J; Pilgrim A
    Headache; 1991 Apr; 31(4):205-9. PubMed ID: 1646775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
    Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
    Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing migraine headaches experienced by patients who self-report with menstrually related migraine: a prospective, placebo-controlled study with oral sumatriptan.
    Dowson AJ; Massiou H; Aurora SK
    J Headache Pain; 2005 Apr; 6(2):81-7. PubMed ID: 16362647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults?
    Hämäläinen ML; Hoppu K; Santavuori P
    Neurology; 1997 Apr; 48(4):1100-3. PubMed ID: 9109909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of sc alniditan vs. sc sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial.
    Diener HC; Tfelt-Hansen P; de Beukelaar F; Ferrari MD; Olesen J; Dahlöf C; Mathew N;
    Cephalalgia; 2001 Jul; 21(6):672-9. PubMed ID: 11531899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice.
    Jensen K; Tfelt-Hansen P; Hansen EW; Krøis EH; Pedersen OS
    Cephalalgia; 1995 Oct; 15(5):423-9. PubMed ID: 8536304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache.
    Cull RE; Price WH; Dunbar A
    J Neurol Neurosurg Psychiatry; 1997 May; 62(5):490-5. PubMed ID: 9153607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
    Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S
    Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular effects of 5-HT1B/1D-receptor agonists in patients with migraine headaches.
    de Hoon JN; Willigers JM; Troost J; Struijker-Boudier HA; Van Bortel LM
    Clin Pharmacol Ther; 2000 Oct; 68(4):418-26. PubMed ID: 11061582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, placebo-controlled, crossover study of early-intervention with sumatriptan 85/naproxen sodium 500 in (truly) episodic migraine: what's neck pain got to do with it?
    Calhoun AH; Ford S
    Postgrad Med; 2014 Mar; 126(2):86-90. PubMed ID: 24685971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs.
    Iversen HK; Olesen J
    Cephalalgia; 1996 Oct; 16(6):412-8. PubMed ID: 8902249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.